Intensified insulin therapy and the risk of severe hypoglycaemia

Diabetologia

Volumn 40, Issue 8, 1997, Pages 926-932

  Bott, S ^a   Bott, U ^a   Berger, M ^a   Muhlhauser I ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Centre effect; HbA(1c); Hypoglycaemia; Insulin therapy; Patient education

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PRIORITY JOURNAL;

ADULT; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; LOGISTIC MODELS; MALE; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0030754515     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050769     Document Type: Article

References (37)

1. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes-mellitus. N Engl J Med 329: 977-986
2. Egger M, Davey Smith G, Diem P (1996) Risk of adverse effects of intensified treatment IDDM: a meta-analysis. Diabetologia 39 [Suppl]:A52 (Abstract)
3. The Diabetes Control and Complications Trial Research Group (1995) Implementation of treatment protocols in the DCCT. Diabetes Care 18: 361-376
4. Pless IB, Heller A, Belmonte M, Zvagulis I (1988) Expected diabetic control in childhood and psychosocial functioning in early adult life. Diabetes Care 11: 387-392
5. Aman J, Karlsson I, Wranne L (1989) Symptomatic hypoglycaemia in childhood diabetes: a population-based questionnaire study. Diabet Med 6: 257-261
6. MacLeod KM, Hepburn DA, Frier BM (1993) Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet Med 10: 238-245
7. Pieber TR, Brunner GA, Schnedel WJ, Schattenberg S, Kaufmann P, Krejs GJ (1995) Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care 18: 625-630
8. 1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia. Diabetologia 39: 677-686
9. Mecklenburg RS, Benson EA, Benson JW et al. (1994) Acute complications associated with insulin infusion pump therapy. JAMA 252: 3265-3269
10. Jörgens V, Grüsser M, Bott U, Mühlhauser I, Berger M (1993) Effective and safe translation of intensified insulin therapy to general internal medicine departments. Diabetologia 36: 99-105
11. Bending JJ, Pickup JC, Keen H (1985) Frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion. Am J Med 79: 685-691
12. Chantelau E, Spraul M, Mühlhauser I, Gause R, Berger M (1989) Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience. Diabetologia 32: 421-426
13. Mühlhauser I, Bruckner I, Berger M et al. (1987) Evaluation of an intensified treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study. Diabetologia 30: 681-690
14. Starostina EG, Antsiferov M, Galstyan GR et al. (1994) Effectiveness and cost-benefit analysis of intensive treatment and teaching programmes for type 1 (insulin dependent) diabetes mellitus in Moscow-blood glucose versus urine glucose self-monitoring. Diabetologia 37: 170-176
15. Berger M, Mühlhauser I (1995) Implementation of intensified insulin therapy: a European perspective. Diabet Med 12: 201-208
16. The Diabetes Control and Complications Trial Research Group (1991) Epidemiology of severe hypoglycaemia in the Diabetes Control and Complications Trial. Am J Med 90: 450-459
17. Wang PH, Lau J, Chalmers TC (1993) Meta-analysis of effects of intensive blood-glucose control on late complications of type 1 diabetes. Lancet 341: 1306-1309
18. Mühlhauser I, Bott U, Overmann H et al. (1995) Liberalized diet in patients with type 1 diabetes. J Int Med 237: 591-597
19. Bott U, Jörgens V, Grüsser M, Bender R, Mühlhauser I, Berger M (1994) Predictors of glycaemic control in type 1 diabetic patients after participation in an intensified treatment and teaching programme. Diabet Med 11: 362-371
20. Mühlhauser I, Bender R, Bott U et al. (1996) Cigarette smoking and the progression of retinopathy and nephropathy in type 1 diabetes. Diabet Med 13: 536-543
21. Scholz V, Grüßer M, Bott U, Jörgens V (1990) Unterrichtskarten zur Schulung von Typ-I-Diabetikern. Kirchheim Verlag, Mainz
22. Bott U, Scholz V, Grüßer M, Jung V, Jörgens V, Berger M (1988) Evaluation of a knowledge test with 546 type 1 (insulin-dependent) diabetic patients in 10 centres. Diabetologia 31 [Suppl]:473A (Abstract)
23. Bott U (1996) Psychosoziale Aspekte der Krankheitsbewältigung und ihre Beziehung zum Therapieerfolg: Evaluation krankheitsspezifischer Fragebogen bei Typ-I-Diabetikern. Peter Lang Verlag, Frankfurt
24. Dunn SM, Smartt HH, Beeney LJ, Turtle JR (1986) Measurement of emotional adjustment in diabetic patients: Validity and reliability of ATT39. Diabetes Care 9: 480-489
25. Bott U (1995) Emotionale Einstellungen bei Typ-I-Diabetikern: Streß und Streßbewältigung. In: Kohlmann CW, Kulzer B (eds.) Diabetes und Psychologie - Diagnostische Ansätze. Hans Huber, Bern Göttingen Toronto Seattle, pp 83-96
26. Brosius G (1988) SPSS/PC + Basics and graphics. Mc Graw-Hill, Hamburg New York
27. Brosius G (1989) SPSS/PC + Advanced statistics and tables. Mc Graw-Hill, Hamburg New York
28. SAS Technical Report P-200, SAS/STAT Software (1990) CALIS and LOGISTIC Procedures, Release 6.04. SAS Institute Inc., Cary, NC
29. The Diabetes Control and Complications Trial Research Group (1987) Diabetes control and complications trial (DCCT): Results of feasibility study. Diabetes Care 10: 1-19
30. Fukuda M, Tanaka A, Tahara Y et al. (1988) Correlation between minimal secretory capacity of pancreatic b-cells and stability of diabetic control. Diabetes 37: 81-88
31. The DCCT Research Group (1987) Effects of age, duration and treatment of insulin dependent diabetes mellitus on residual b-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J Clin Endocrinol Metab 65: 30-37
32. Reynolds C, Molnar GD, Horwitz DL, Rubenstein AH, Taylor WF, Jiang NS (1977) Abnomalities of endogenous glucagon and insulin in unstable diabetes. Diabetes 26: 36
33. Steffes M, Tamborlane W, Becker D, Palmer J, Cleary P (1996) The effect of intensive treatment on residual b-cell function in the Diabetes Control and Complications Trial. Diabetes 45: 18A
34. Wysocki T, Hough BS, Ward KM, Green LB (1992) Diabetes mellitus in the transition to adulthood: adjustment, self-care, and health status. J Dev Behav Pediatr 13: 194-201
35. Cox DJ, Gonder-Frederick L (1992) Major developments in behavioral diabetes research. J Consult Clin Psychol 60: 628-638
36. Rubin RR, Peyrot M (1992) Psychosocial problems and interventions in diabetes: a review of the literature. Diabetes Care 15: 1640-1657
37. The Diabetes Control and Complications Trial Research Group (1995) Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care 18: 1415-1427